Takeda Signs Option to Market Ascentage's Blood-Cancer Drug [BNN Bloomberg (Canada)]
Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet [Yahoo! Finance]
Blood Brain Barrier Market Untapped Growth Opportunities Analysis - Latest Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]
AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic? [Yahoo! Finance]
AC Immune SA (NASDAQ: ACIU) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.